Insider Transactions in Q3 2024 at Actuate Therapeutics, Inc. (ACTU)
Insider Transaction List (Q3 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 14
2024
|
Todd S Thomson Director |
SELL
Open market or private sale
|
Indirect |
18,750
-1.56%
|
$150,000
$8.0 P/Share
|
|
Aug 14
2024
|
Todd S Thomson Director |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
28,464
+2.31%
|
$142,320
$5.27 P/Share
|
|
Aug 14
2024
|
Todd S Thomson Director |
BUY
Conversion of derivative security
|
Indirect |
2,577,312
+30.43%
|
-
|
|
Aug 14
2024
|
Bios Equity Cof, LP Director |
SELL
Open market or private sale
|
Indirect |
24,999
-1.74%
|
$224,991
$9.0 P/Share
|
|
Aug 14
2024
|
Bios Equity Cof, LP Director |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
37,951
+2.57%
|
$189,755
$5.27 P/Share
|
|
Aug 14
2024
|
Bios Equity Cof, LP Director |
BUY
Conversion of derivative security
|
Indirect |
9,380,699
+37.41%
|
-
|
|
Aug 14
2024
|
Bios Equity Cof, LP Director |
BUY
Open market or private purchase
|
Indirect |
500,000
+36.47%
|
$4,000,000
$8.0 P/Share
|
|
Aug 14
2024
|
Aaron G.L. Fletcher Director |
SELL
Open market or private sale
|
Indirect |
24,999
-1.74%
|
$224,991
$9.0 P/Share
|
|
Aug 14
2024
|
Aaron G.L. Fletcher Director |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
37,951
+2.57%
|
$189,755
$5.27 P/Share
|
|
Aug 14
2024
|
Aaron G.L. Fletcher Director |
BUY
Conversion of derivative security
|
Indirect |
9,380,699
+37.41%
|
-
|
|
Aug 14
2024
|
Aaron G.L. Fletcher Director |
BUY
Open market or private purchase
|
Indirect |
500,000
+36.47%
|
$4,000,000
$8.0 P/Share
|
|
Aug 14
2024
|
Leslie W. Kreis > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
24,999
-1.74%
|
$224,991
$9.0 P/Share
|
|
Aug 14
2024
|
Leslie W. Kreis > 10% Shareholder |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
37,951
+2.57%
|
$189,755
$5.27 P/Share
|
|
Aug 14
2024
|
Leslie W. Kreis > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
9,380,699
+37.41%
|
-
|
|
Aug 14
2024
|
Leslie W. Kreis > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
500,000
+36.47%
|
$4,000,000
$8.0 P/Share
|